Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GIMERACIL for Gastric cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 27 adverse event reports in the FDA FAERS database where GIMERACIL was used for Gastric cancer.

Most Reported Side Effects for GIMERACIL

Side Effect Reports % Deaths Hosp.
Disease progression 16 18.8% 4 2
Decreased appetite 11 12.9% 2 5
Diarrhoea 11 12.9% 1 5
Anaemia 9 10.6% 0 1
Drug ineffective 8 9.4% 3 1
Nausea 8 9.4% 0 2
Vomiting 8 9.4% 0 0
Thrombocytopenia 7 8.2% 1 2
Myelosuppression 6 7.1% 0 1
Neutropenia 6 7.1% 0 0
Bone marrow failure 5 5.9% 0 3
Fatigue 5 5.9% 1 1
Pyrexia 5 5.9% 0 1

Other Indications for GIMERACIL

Chemotherapy (6)

Other Drugs Used for Gastric cancer

NIVOLUMAB (3,856) OXALIPLATIN (2,711) CAPECITABINE (2,054) RAMUCIRUMAB (1,257) FLUOROURACIL (1,062) PACLITAXEL (994) TRASTUZUMAB (917) CISPLATIN (802) GIMERACIL\OTERACIL\TEGAFUR (725) DOCETAXEL (598)

Related Pages

GIMERACIL Full Profile All Gastric cancer Drugs GIMERACIL Demographics GIMERACIL Timeline